KAUST and King Faisal Specialist Hospital and Research Centre (KFSH&RC) are collaborating to develop bioelectronic sensors for rapid pathogen detection. These sensors aim to provide cheap and accurate results, potentially replacing conventional lab tests. A COVID-19 saliva test developed by KAUST researchers showed comparable sensitivity to PCR tests with a 15-minute turnaround. Why it matters: This partnership accelerates the development of novel diagnostic tools, which could improve healthcare accessibility in remote areas and low-income countries within the region.
KAUST researchers Yichen Cai and Jie Shen, led by Dr. Vincent Tung, are developing electronic skin (e-skin) using 2D materials like MXenes. Their research, published in Science Advances, focuses on mimicking human skin functions like sensing and adapting to stimuli. The team leverages the unique properties of 2D materials to create flexible and efficient electronic systems for next-generation electronics. Why it matters: This work advances materials science in the region, potentially enabling breakthroughs in flexible electronics, healthcare monitoring, and robotics.
Sahika Inal, an assistant professor of bioscience at KAUST, focuses on organic electronic materials for clinical health monitoring. Her research involves finding functional polymers and designing electronic platforms that connect biological systems with electronics. Inal notes that KAUST's facilities and collaborative environment in BESE have been crucial for her research and team growth since 2016. Why it matters: This highlights KAUST's role in fostering interdisciplinary research and attracting talented scientists in the emerging field of bioelectronics.
KAUST researchers in the Sensors Lab are developing neuromorphic circuits for vision sensors, drawing inspiration from the human eye. They created flexible photoreceptors using hybrid perovskite materials, with capacitance tunable by light stimulation, mimicking the human retina. The team collaborates with experts in image characterization and brain pattern recognition to connect the 'eye' to the 'brain' for object identification. Why it matters: This biomimetic approach promises advancements in AI, machine learning, and smart city development within the region.
KAUST researchers created a flexible temperature array by drawing a resistor structure with a silver conductive ink pen on Post-it paper. The array functions as an artificial skin sensor. The device demonstrates a low-cost approach to wearable sensors. Why it matters: This research offers a path to scalable and accessible sensor technology for health monitoring and other applications in the region.
KAUST held its third annual Sensor Initiative, hosting 70 delegates from KAUST and international institutions like MIT and UCLA. The interdisciplinary meeting focused on transforming sensor technologies and exploring applications. Researchers from KAUST and abroad presented on topics like chemical sensors and sustainable ecosystems. Why it matters: The initiative demonstrates KAUST's commitment to advancing sensor technology and fostering collaboration between local and international experts.
KAUST is developing wearable sensors to monitor athletes' physiological responses, aiming to enhance performance and prevent injuries, aligning with Saudi Vision 2030. In partnership with a global motor racing team, KAUST is using electrochemical sensors to monitor drivers’ hydration and stress markers, enabling customized interventions. KAUST's wearable technology could continuously observe physiological parameters during training and in competition, helping coaches predict injuries and optimize training. Why it matters: These advancements in sensor technology and data analysis position KAUST as a key player in sports training innovation and could significantly impact athletic performance and healthcare in the region.
KAUST's Sciencetown podcast episode 23 features researcher Dana Al-Sulaiman discussing portable biosensing technologies for cancer detection. These devices aim to enable liquid biopsies for early screening and personalized treatment. The biosensors gather clinical information from biological samples to inform clinical decisions. Why it matters: This research can advance non-invasive diagnostics and personalized medicine in the region.